NRSNW short interest
NeuroSense Therapeutics Ltd. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 893 |
|---|---|
| Change vs prior report | -886 (-49.8%) |
| Change over six months | -82.2% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 2,775 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
NRSNW short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 893 | -49.8% | 1.00 | 2,775 |
| 2026-09-15 | 1,779 | -19.8% | 4.80 | 371 |
| 2026-08-31 | 2,218 | -2.3% | 2.42 | 917 |
| 2026-08-14 | 2,271 | -14.4% | 9.38 | 242 |
| 2026-07-31 | 2,653 | -34.7% | 4.29 | 619 |
| 2026-07-15 | 4,063 | +2.5% | 11.74 | 346 |
| 2026-06-30 | 3,965 | +0.8% | 1.65 | 2,398 |
| 2026-06-15 | 3,934 | +16.1% | 1.13 | 3,487 |
| 2026-05-29 | 3,390 | -14.1% | 2.53 | 1,339 |
| 2026-05-15 | 3,946 | +22.9% | 9.82 | 402 |
| 2026-04-30 | 3,211 | -5.9% | 15.00 | 214 |
| 2026-04-15 | 3,411 | -31.9% | 4.06 | 841 |
| 2026-03-31 | 5,011 | -10.7% | 10.87 | 461 |
| 2026-03-13 | 5,611 | -8.2% | 62.34 | 90 |
| 2026-02-27 | 6,111 | -6.1% | 13.09 | 467 |
| 2026-02-13 | 6,511 | -13.5% | 3.70 | 1,762 |
| 2026-01-30 | 7,529 | -16.5% | 11.64 | 647 |
| 2026-01-15 | 9,014 | -0.1% | 160.96 | 56 |
| 2025-12-31 | 9,021 | +0.2% | 20.88 | 432 |
| 2025-12-15 | 9,001 | -15.6% | 2.42 | 3,722 |
| 2025-11-28 | 10,658 | +67.3% | 3.19 | 3,344 |
| 2025-11-14 | 6,372 | -8.1% | 1.61 | 3,959 |
| 2025-10-31 | 6,937 | -13.0% | 13.02 | 533 |
| 2025-10-15 | 7,971 | +109.6% | 4.04 | 1,975 |
| 2025-09-30 | 3,803 | -15.8% | 2.58 | 1,475 |
import finzdata as yf
yf.Ticker("NRSNW").short_interest # every report since 2017
yf.Client().short_interest(["NRSNW"], start="2018-01-01")Healthcare short interest · NRSNW price history · Who owns NRSNW · All short interest